Tapewire

Nasdaq · USD

BMRN

BIOMARIN PHARMACEUTICAL INC

Export transactions ↓
Tapewire entity
2404
SEC CIK
0001048477
Parsed reports
685

Last 12 months

Inside the activity.

0 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202601
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 09, 2024 Filed May 13, 2024 19:57 UTC Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 20,000 $0.00 Strike: $63.10 $0.00
Disclosure

SEC source: 0001048477-24-000079 · wk-form4_1715630235.xml · derivative · entry 8

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,000

Underlying: Common Stock · 20,000 shares

Expires 2024-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
May 09, 2024 Filed May 13, 2024 19:57 UTC SaleCommon Stock 20,000 $81.62 $1,632,400.00
Disclosure

SEC source: 0001048477-24-000079 · wk-form4_1715630235.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 474,994

F1 · date: Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.

Read SEC document
May 09, 2024 Filed May 13, 2024 19:57 UTC Exercise / conversionCommon Stock 20,000 $63.10 $1,262,000.00
Disclosure

SEC source: 0001048477-24-000079 · wk-form4_1715630235.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 494,994

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.

Read SEC document
May 03, 2024 Filed May 7, 2024 21:58 UTC
Guyer Charles GregEVP, Chief Technical Officer
Tax withholdingCommon Stock 4,440 $82.44 $366,033.60
Disclosure

SEC source: 0001048477-24-000077 · wk-form4_1715119099.xml · nonDerivative · entry 2

Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,132

Read SEC document
May 02, 2024 Filed May 6, 2024 20:45 UTC
Davis George EricEVP, Chief Legal Officer
Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 1,850 $0.00 Strike: $63.10 $0.00
Disclosure

SEC source: 0001048477-24-000075 · wk-form4_1715028307.xml · derivative · entry 4

Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,850

Underlying: Common Stock · 1,850 shares

Expires 2024-06-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
May 02, 2024 Filed May 6, 2024 20:45 UTC
Davis George EricEVP, Chief Legal Officer
SaleCommon Stock 1,850 $85.01 $157,268.50
Disclosure

SEC source: 0001048477-24-000075 · wk-form4_1715028307.xml · nonDerivative · entry 3

Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,157

F2 · date: Trade made pursuant to a 10b5-1 plan executed on September 13, 2023.

F3 · price: The price in column 4 is the weighted average price. The purchase price actually received ranged from $85.00 to $85.03. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
May 02, 2024 Filed May 6, 2024 20:45 UTC
Davis George EricEVP, Chief Legal Officer
Exercise / conversionCommon Stock 1,850 $63.10 $116,735.00
Disclosure

SEC source: 0001048477-24-000075 · wk-form4_1715028307.xml · nonDerivative · entry 2

Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 58,007

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · date: Trade made pursuant to a 10b5-1 plan executed on September 13, 2023.

Read SEC document
May 02, 2024 Filed May 6, 2024 20:40 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
SaleCommon Stock 5,000 $82.91 $414,550.00
Disclosure

SEC source: 0001048477-24-000073 · wk-form4_1715028037.xml · nonDerivative · entry 2

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 66,767

F2 · date: Trade made pursuant to a 10b5-1 plan executed on April 13, 2023.

Read SEC document
April 30, 2024 Filed May 6, 2024 20:45 UTC
Davis George EricEVP, Chief Legal Officer
GrantCommon Stock 301 $68.65 $20,662.45
Disclosure

SEC source: 0001048477-24-000075 · wk-form4_1715028307.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 56,157

F1 · date: Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 30, 2024 Filed May 6, 2024 20:40 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
GrantCommon Stock 300 $68.65 $20,593.80
Disclosure

SEC source: 0001048477-24-000073 · wk-form4_1715028037.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,767

F1 · date: Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 30, 2024 Filed May 7, 2024 21:58 UTC
Guyer Charles GregEVP, Chief Technical Officer
GrantCommon Stock 245 $68.65 $16,818.27
Disclosure

SEC source: 0001048477-24-000077 · wk-form4_1715119099.xml · nonDerivative · entry 1

Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,572

F1 · date: Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 30, 2024 Filed May 31, 2024 22:28 UTC
Mueller BrianEVP, Chief Financial Officer
GrantCommon Stock 300 $68.65 $20,593.80
Disclosure

SEC source: 0001048477-24-000114 · wk-form4_1717194476.xml · nonDerivative · entry 1

Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 72,159

F1 · date: Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 30, 2024 Filed Sep 17, 2024 21:54 UTC
FUCHS HENRY JPresident, Worldwide R&D
GrantCommon Stock 300 $68.65 $20,593.80
Disclosure

SEC source: 0001048477-24-000141 · wk-form4_1726610040.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 197,172

F1 · date: Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan.

Read SEC document
April 12, 2024 Filed Apr 15, 2024 20:21 UTC Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 20,000 $0.00 Strike: $63.10 $0.00
Disclosure

SEC source: 0001048477-24-000063 · wk-form4_1713212473.xml · derivative · entry 9

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 91,000

Underlying: Common Stock · 20,000 shares

Expires 2024-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
April 12, 2024 Filed Apr 15, 2024 20:21 UTC SaleCommon Stock 20,000 $91.26 $1,825,200.00
Disclosure

SEC source: 0001048477-24-000063 · wk-form4_1713212473.xml · nonDerivative · entry 4

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 474,994

F1 · date: Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.

Read SEC document
April 12, 2024 Filed Apr 15, 2024 20:21 UTC Exercise / conversionCommon Stock 20,000 $63.10 $1,262,000.00
Disclosure

SEC source: 0001048477-24-000063 · wk-form4_1713212473.xml · nonDerivative · entry 3

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 494,994

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 20:21 UTC Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 20,000 $0.00 Strike: $63.10 $0.00
Disclosure

SEC source: 0001048477-24-000063 · wk-form4_1713212473.xml · derivative · entry 8

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 111,000

Underlying: Common Stock · 20,000 shares

Expires 2024-06-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · balance_after: Reflects the number of options outstanding after the transactions from this specific stock option grant.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 20:21 UTC SaleCommon Stock 20,000 $90.99 $1,819,800.00
Disclosure

SEC source: 0001048477-24-000063 · wk-form4_1713212473.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 474,994

F1 · date: Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.

Read SEC document
April 11, 2024 Filed Apr 15, 2024 20:21 UTC Exercise / conversionCommon Stock 20,000 $63.10 $1,262,000.00
Disclosure

SEC source: 0001048477-24-000063 · wk-form4_1713212473.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 494,994

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · date: Trade made pursuant to a 10b5-1 plan executed on August 7, 2023.

Read SEC document
April 10, 2024 Filed Apr 12, 2024 19:07 UTC
Burkhart ErinGVP, Chief Accounting Officer
SaleCommon Stock 2,286 $90.00 $205,740.00
Disclosure

SEC source: 0001048477-24-000061 · wk-form4_1712948853.xml · nonDerivative · entry 1

Burkhart Erin · CIK 0001927648 · GVP, Chief Accounting Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,156

F1 · date: Trade made pursuant to a 10b5-1 plan executed on November 29, 2023.

Read SEC document
March 28, 2024 Filed Apr 1, 2024 20:54 UTC
Davis George EricEVP, Chief Legal Officer
SaleCommon Stock 24,602 $88.34 $2,173,340.68
Disclosure

SEC source: 0001048477-24-000054 · wk-form4_1712004839.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,856

F1 · date: Trade made pursuant to a 10b5-1 plan executed on September 13, 2023.

Read SEC document
March 18, 2024 Filed Mar 20, 2024 00:55 UTC
Burkhart ErinGVP, Chief Accounting Officer
Tax withholdingCommon Stock 372 $83.87 $31,199.64
Disclosure

SEC source: 0001048477-24-000050 · wk-form4_1710896100.xml · nonDerivative · entry 2

Burkhart Erin · CIK 0001927648 · GVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,442

Read SEC document
March 18, 2024 Filed Mar 20, 2024 21:13 UTC Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative 10,000 $0.00 Strike: $79.70 $0.00
Disclosure

SEC source: 0001048477-24-000052 · wk-form4_1710969202.xml · derivative · entry 3

Slamon Dennis · CIK 0001603265 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,000 shares

Expires 2024-03-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Reflects the number of options outstanding after the transaction from this specific stock option grant.

Read SEC document
March 18, 2024 Filed Mar 20, 2024 21:13 UTC Tax withholdingCommon Stock 9,510 $83.81 $797,033.10
Disclosure

SEC source: 0001048477-24-000052 · wk-form4_1710969202.xml · nonDerivative · entry 2

Slamon Dennis · CIK 0001603265 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,299

Read SEC document
March 18, 2024 Filed Mar 20, 2024 21:13 UTC Exercise / conversionCommon Stock 10,000 $79.70 $797,000.00
Disclosure

SEC source: 0001048477-24-000052 · wk-form4_1710969202.xml · nonDerivative · entry 1

Slamon Dennis · CIK 0001603265 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,809

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 15, 2024 Filed Mar 20, 2024 00:55 UTC
Burkhart ErinGVP, Chief Accounting Officer
GrantStock Option (Right to Buy Common Stock) · Derivative 7,050 $0.00 Strike: $83.87 $0.00
Disclosure

SEC source: 0001048477-24-000050 · wk-form4_1710896100.xml · derivative · entry 3

Burkhart Erin · CIK 0001927648 · GVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,050

Underlying: Common Stock · 7,050 shares

Expires 2034-03-14

F2 · derivative.exercise_date: Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter.

Read SEC document
March 15, 2024 Filed Mar 20, 2024 00:55 UTC
Burkhart ErinGVP, Chief Accounting Officer
GrantCommon Stock 4,720 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000050 · wk-form4_1710896100.xml · nonDerivative · entry 1

Burkhart Erin · CIK 0001927648 · GVP, Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,814

F1 · price: Restricted stock units granted March 15, 2024. Price not applicable.

Read SEC document
March 15, 2024 Filed Mar 20, 2024 00:53 UTC
Davis George EricEVP, Chief Legal Officer
GrantStock Option (Right to Buy Common Stock) · Derivative 22,990 $0.00 Strike: $83.87 $0.00
Disclosure

SEC source: 0001048477-24-000048 · wk-form4_1710895967.xml · derivative · entry 3

Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,990

Underlying: Common Stock · 22,990 shares

Expires 2034-03-14

F2 · derivative.exercise_date: Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter.

Read SEC document
March 15, 2024 Filed Mar 20, 2024 00:53 UTC
Davis George EricEVP, Chief Legal Officer
Tax withholdingCommon Stock 21,699 $83.87 $1,819,895.13
Disclosure

SEC source: 0001048477-24-000048 · wk-form4_1710895967.xml · nonDerivative · entry 2

Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,458

Read SEC document
March 15, 2024 Filed Mar 20, 2024 00:53 UTC
Davis George EricEVP, Chief Legal Officer
GrantCommon Stock 10,260 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000048 · wk-form4_1710895967.xml · nonDerivative · entry 1

Davis George Eric · CIK 0001380710 · EVP, Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 102,157

F1 · price: Restricted stock units granted March 15, 2024. Price not applicable.

Read SEC document
March 15, 2024 Filed Mar 20, 2024 00:50 UTC
Guyer Charles GregEVP, Chief Technical Officer
GrantStock Option (Right to Buy Common Stock) · Derivative 23,630 $0.00 Strike: $83.87 $0.00
Disclosure

SEC source: 0001048477-24-000046 · wk-form4_1710895840.xml · derivative · entry 3

Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,630

Underlying: Common Stock · 23,630 shares

Expires 2034-03-14

F2 · derivative.exercise_date: Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter.

Read SEC document
March 15, 2024 Filed Mar 20, 2024 00:50 UTC
Guyer Charles GregEVP, Chief Technical Officer
Tax withholdingCommon Stock 20,424 $83.87 $1,712,960.88
Disclosure

SEC source: 0001048477-24-000046 · wk-form4_1710895840.xml · nonDerivative · entry 2

Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,327

Read SEC document
March 15, 2024 Filed Mar 20, 2024 00:50 UTC
Guyer Charles GregEVP, Chief Technical Officer
GrantCommon Stock 10,550 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000046 · wk-form4_1710895840.xml · nonDerivative · entry 1

Guyer Charles Greg · CIK 0001811096 · EVP, Chief Technical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 98,751

F1 · price: Restricted stock units granted March 15, 2024. Price not applicable.

Read SEC document
March 15, 2024 Filed Mar 20, 2024 00:48 UTC
Mueller BrianEVP, Chief Financial Officer
GrantStock Option (Right to Buy Common Stock) · Derivative 25,540 $0.00 Strike: $83.87 $0.00
Disclosure

SEC source: 0001048477-24-000044 · wk-form4_1710895692.xml · derivative · entry 3

Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,540

Underlying: Common Stock · 25,540 shares

Expires 2034-03-14

F2 · derivative.exercise_date: Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter.

Read SEC document
March 15, 2024 Filed Mar 20, 2024 00:48 UTC
Mueller BrianEVP, Chief Financial Officer
Tax withholdingCommon Stock 20,789 $83.87 $1,743,573.43
Disclosure

SEC source: 0001048477-24-000044 · wk-form4_1710895692.xml · nonDerivative · entry 2

Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,859

Read SEC document
March 15, 2024 Filed Mar 20, 2024 00:48 UTC
Mueller BrianEVP, Chief Financial Officer
GrantCommon Stock 11,400 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000044 · wk-form4_1710895692.xml · nonDerivative · entry 1

Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,648

F1 · price: Restricted stock units granted March 15, 2024. Price not applicable.

Read SEC document
March 15, 2024 Filed Mar 20, 2024 00:46 UTC
FUCHS HENRY JPresident, Worldwide R&D
GrantStock Option (Right to Buy Common Stock) · Derivative 40,860 $0.00 Strike: $83.87 $0.00
Disclosure

SEC source: 0001048477-24-000042 · wk-form4_1710895563.xml · derivative · entry 3

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,860

Underlying: Common Stock · 40,860 shares

Expires 2034-03-14

F2 · derivative.exercise_date: Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter.

Read SEC document
March 15, 2024 Filed Mar 20, 2024 00:46 UTC
FUCHS HENRY JPresident, Worldwide R&D
Tax withholdingCommon Stock 33,485 $83.87 $2,808,386.95
Disclosure

SEC source: 0001048477-24-000042 · wk-form4_1710895563.xml · nonDerivative · entry 2

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,872

Read SEC document
March 15, 2024 Filed Mar 20, 2024 00:46 UTC
FUCHS HENRY JPresident, Worldwide R&D
GrantCommon Stock 18,240 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000042 · wk-form4_1710895563.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 230,357

F1 · price: Restricted stock units granted March 15, 2024. Price not applicable.

Read SEC document
March 15, 2024 Filed Mar 20, 2024 00:42 UTC
Hardy AlexanderDirector · Chief Executive Officer
GrantStock Option (Right to Buy Common Stock) · Derivative 44,050 $0.00 Strike: $83.87 $0.00
Disclosure

SEC source: 0001048477-24-000040 · wk-form4_1710895361.xml · derivative · entry 2

Hardy Alexander · CIK 0002001910 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,050

Underlying: Common Stock · 44,050 shares

Expires 2034-03-14

F2 · derivative.exercise_date: Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter.

Read SEC document
March 15, 2024 Filed Mar 20, 2024 00:42 UTC
Hardy AlexanderDirector · Chief Executive Officer
GrantCommon Stock 32,780 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000040 · wk-form4_1710895361.xml · nonDerivative · entry 1

Hardy Alexander · CIK 0002001910 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,151

F1 · price: Restricted stock units granted March 15, 2024. Price not applicable.

Read SEC document
March 15, 2024 Filed Mar 20, 2024 00:40 UTC Tax withholdingCommon Stock 85,209 $83.87 $7,146,478.83
Disclosure

SEC source: 0001048477-24-000038 · wk-form4_1710895245.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 474,994

Read SEC document
March 15, 2024 Filed Mar 20, 2024 00:36 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
Tax withholdingCommon Stock 22,580 $83.87 $1,893,784.60
Disclosure

SEC source: 0001048477-24-000036 · wk-form4_1710894971.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,467

Read SEC document
March 06, 2024 Filed Mar 7, 2024 22:35 UTC SaleCommon Stock 1,000 $86.71 $86,713.00
Disclosure

SEC source: 0001048477-24-000032 · wk-form4_1709850926.xml · nonDerivative · entry 2

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 560,203

Read SEC document
March 05, 2024 Filed Mar 7, 2024 23:54 UTC
FUCHS HENRY JPresident, Worldwide R&D
SaleCommon Stock 35,341 $85.18 $3,010,395.86
Disclosure

SEC source: 0001048477-24-000034 · wk-form4_1709855648.xml · nonDerivative · entry 1

FUCHS HENRY J · CIK 0001197355 · President, Worldwide R&D

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 212,117

F1 · price: The price in column 4 is the weighted average price. The purchase price actually received ranged from $85.01 to $85.31. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 22:35 UTC SaleCommon Stock 1,000 $85.51 $85,510.00
Disclosure

SEC source: 0001048477-24-000032 · wk-form4_1709850926.xml · nonDerivative · entry 1

BIENAIME JEAN JACQUES · CIK 0001221590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 561,203

Read SEC document
March 05, 2024 Filed Mar 7, 2024 22:32 UTC
Ajer Jeffrey RobertEVP, Chief Commercial Officer
SaleCommon Stock 4,000 $87.07 $348,280.00
Disclosure

SEC source: 0001048477-24-000030 · wk-form4_1709850751.xml · nonDerivative · entry 1

Ajer Jeffrey Robert · CIK 0001557533 · EVP, Chief Commercial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 94,047

F1 · date: Trade made pursuant to a 10b5-1 plan executed on April 13, 2023.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:18 UTC
Mueller BrianEVP, Chief Financial Officer
GrantCommon Stock 6,103 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000028 · wk-form4_1709245123.xml · nonDerivative · entry 3

Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,248

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

F5 · shares: Represents the total number of RSUs earned pursuant to a formula based on non-GAAP income over three, one-year periods spanning 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:18 UTC
Mueller BrianEVP, Chief Financial Officer
GrantCommon Stock 8,802 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000028 · wk-form4_1709245123.xml · nonDerivative · entry 2

Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,145

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

F4 · shares: Represents the total number of RSUs earned pursuant to a formula based on the number and nature of strategic goals achieved during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 22:18 UTC
Mueller BrianEVP, Chief Financial Officer
GrantCommon Stock 20,220 $0.00 $0.00
Disclosure

SEC source: 0001048477-24-000028 · wk-form4_1709245123.xml · nonDerivative · entry 1

Mueller Brian · CIK 0001514980 · EVP, Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,343

F1 · date: Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis.

F2 · shares: Represents the total number of RSUs earned pursuant to a formula based on relative total shareholder return during 2021 through 2023 set forth in the performance-based RSU awards previously granted under the Issuer's 2017 Equity Incentive Plan.

F3 · shares: Although earned, the RSUs only vest according to the following schedule: vests on March 15, 2024, subject to the reporting person's continued service through that date, subject to earlier vesting upon certain events.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.